TRIAGE OF ABNORMAL POSTMENOPAUSAL BLEEDING - A COMPARISON OF ENDOMETRIAL BIOPSY AND TRANSVAGINAL SONOHYSTEROGRAPHY VERSUS FRACTIONAL CURETTAGE WITH HYSTEROSCOPY
Lp. Oconnell et al., TRIAGE OF ABNORMAL POSTMENOPAUSAL BLEEDING - A COMPARISON OF ENDOMETRIAL BIOPSY AND TRANSVAGINAL SONOHYSTEROGRAPHY VERSUS FRACTIONAL CURETTAGE WITH HYSTEROSCOPY, American journal of obstetrics and gynecology, 178(5), 1998, pp. 956-961
OBJECTIVE: We sought to compare the combined diagnostic reliability of
sonohysterography and endometrial biopsy with fractional curettage wi
th hysteroscopy in the initial evaluation of postmenopausal women with
abnormal uterine bleeding. STUDY DESIGN: This year-long, prospective,
controlled, clinical investigation was initiated Sept. 1, 1995. All p
ostmenopausal women with abnormal uterine bleeding were offered inclus
ion with 104 enrolled. An endometrial biopsy was performed at the time
of initial evaluation. Routine transvaginal ultrasonography was then
used to measure the uterus, ovaries. and endometrial stripe thickness,
followed immediately by sonohysterography to evaluate the symmetry of
endometrial wall thickness and delineate any intraluminal masses. Def
initive histopathologic sampling was obtained by fractional curettage
with hysteroscopy and statistically compared with the diagnoses arrive
d at by endometrial biopsy and sonohysterography. RESULTS: The combina
tion of endometrial biopsy and transvaginal sonohysterography positive
ly correlated with the surgical findings>95% of the time, with a sensi
tivity and specificity of 94% and 96%, respectively (confidence interv
al 91% to 99%). No patients with endometrial hyperplasia or cancer wer
e misdiagnosed. CONCLUSIONS: Sonohysterography combined with endometri
al biopsy is a reliable office tool for evaluating postmenopausal wome
n with abnormal uterine bleeding. Medical management of those patients
identified as having no endometrial abnormalities can he considered w
ith confidence, while saving the cost and surgical risk of fractional
curettage. Patients with intraluminal masses should be referred for su
rgical management in a timely fashion.